Pandora, Gap Post R...
Health Care: Drugs
Warner Chilcott PLC (WCRX: NASDAQ)
$20.00 -0.25 | -1.23%
05/23/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 403.00M | 171.15M | 170.97M | 514.12M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | -393.10M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 102.00M | 92.52M | 9.60M | -18.13M |
| (Increase) Decrease in Inventories | -21.00M | -46.29M | -8.40M | -8.51M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -172.00M | 91.12M | -66.21M | -15.52M |
| (Decrease) Increase In Other Current Liabilities | -82.00M | 41.84M | -30.12M | 35.61M |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 138.00M | 80.41M | 140.00M | 98.10M |
| Net Cash From Continuing Operations | 897.00M | 1.18B | 947.44M | 501.91M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 897.00M | 1.18B | 947.44M | 501.91M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -63.00M | -46.24M | -497.94M | -55.61M |
| Acquisitions | 0.00 | 0.00 | 0.00 | -2.87B |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 1.00B |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -63.00M | -46.24M | -497.94M | -1.92B |
| Issuance of Debt | 600.00M | 3.00B | 2.76B | 2.95B |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 8.00M | 4.90M | 7.80M | 3.97M |
| Repayment of Long-Term Debt | -487.00M | -3.81B | -1.12B | -873.10M |
| Repurchase of Capital Stock | -32.00M | -55.71M | 0.00 | 0.00 |
| Payment of Cash Dividends | -1.05B | 0.00 | -2.14B | 0.00 |
| Other Financing Charges, Net | -15.00M | -48.57M | -84.03M | -154.69M |
| Net Cash From Financing Activities | -978.00M | -913.98M | -574.84M | 1.93B |
| Effect of Exchange Rate Changes | 2.00M | -2.30M | -11.86M | 0.00 |
| Net Change in Cash & Cash Equivalents | -142.00M | 214.54M | -137.20M | 503.10M |
Portfolios with WCRX
- Portfolio NameUser Type
- UserAbsolute Fusion
- UserKJP Autumn Moonlight
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ProD.E. Shaw
- ProPrivate Capital Management
- UserStock Game
- ContributorRelative Strength Stocks 09...
- ContributorTop Stocks of the 10 Best M...
Latest WCRX Headlines from TheStreet
- Warner Chilcott Stock Falls On Unusually High Volume (WCRX) 05.22.13 | 03:05 pm
- The Deal: Actavis Extends Gains Following Warner Deal 05.21.13 | 03:05 pm
- Warner Chilcott Reaches New 52-Week High (WCRX) 05.21.13 | 02:05 pm
- Stocks Slip on Concerns Markets Overpriced 05.20.13 | 04:05 pm
- Ireland Welcomes Watson Pharmaceuticals, an American Success 05.20.13 | 02:05 pm
- Dow Dull Except for Deal Stocks
05.20.13 | 11:05 am - Warner Chilcott Rises On Unusually High Volume (WCRX) 05.20.13 | 10:05 am
- The Deal: Actavis Plays Hunter in $8.5 Billion Deal for Ireland's Warner Chilcott 05.20.13 | 10:05 am
- Futures Slip as Investors Seek Fed Clarity 05.20.13 | 09:05 am
- Announcement Under Irish Takeover Rules Revision To Relevant Securities In Issue 05.20.13 | 09:05 am
Press Releases for WCRX
- Actavis To Acquire Warner Chilcott To Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company - PR Newswire 05.20.13 | 07:05 am
- Warner Chilcott Prices Secondary Equity Offering - PR Newswire 03.10.11 | 06:03 pm
- Warner Chilcott Announces Secondary Equity Offering - PR Newswire 03.08.11 | 05:03 pm
- Warner Chilcott To Present At The Goldman Sachs Leveraged Finance Healthcare Conference - PR Newswire 03.04.11 | 04:03 pm
- Warner Chilcott Seeks To Refinance Its Existing Credit Agreement - PR Newswire 03.02.11 | 05:03 pm
- Warner Chilcott To Present At The 2011 RBC Capital Markets' Healthcare Conference - PR Newswire 02.22.11 | 08:02 am
- Warner Chilcott To Present At The Citi 2011 Global Health Care Conference - PR Newswire 02.18.11 | 04:02 pm
- Warner Chilcott Announces Earnings Release Date And Conference Call For Fourth Quarter And Full Year 2010 Financial Results - PR Newswire 02.15.11 | 04:02 pm
- Warner Chilcott Announces 2011 Financial Guidance Conference Call - PR Newswire 01.27.11 | 08:01 am
- Warner Chilcott To Present At The 29th Annual J.P. Morgan Healthcare Conference - PR Newswire 01.04.11 | 09:01 am
Partner Headlines for WCRX
- UPDATE: Citigroup Initiates Warner Chilcott PLC with Neutral on Pending Activities Execution - Benzinga 04.05.13 | 09:04 am
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- Stocks Slip Into Red Zone; Wal-Mart Down In Heavy Trade - Investor's Business Daily 02.15.13 | 12:02 pm
- Warner Chilcott Tops, View Raised - Analyst Blog - Zacks 11.15.12 | 09:11 am
- Apricus, Takeda Ink Marketing Deal - Analyst Blog - NASDAQ 09.14.12 | 10:09 pm
- Apricus, Takeda Ink Marketing Deal - Analyst Blog - Zacks 09.14.12 | 06:09 pm
- Warner Chilcott Plc Enters Oversold Territory - Tale of the Tape - NASDAQ 09.14.12 | 04:09 pm
- Stocks On Track For Upbeat Open On ECB, Economic News - Investor's Business Daily 09.06.12 | 09:09 am
- Warner Chilcott Plc Enters Oversold Territory - Tale of the Tape - NASDAQ 09.04.12 | 03:09 pm
- UPDATE: Morgan Stanley Downgrades Warner Chilcott to Underweight - Benzinga 08.21.12 | 01:08 pm
